Looking for volunteers
U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
NCT07325578 · Precision IO Group · Updated 20 July 2026
- What is being tested
- Percutaneous procedure in the MSK structures of the pelvis and/or the spine
- For
- Bone Tumor; Osteoporosis; Traumatic Fracture
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years and older. About 60 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 28 April 2026, ends March 2027. Registered 8 Jan 2026.
- Results
- None posted yet.
In the researchers' words
The goal of this investigational device exemption is to evaluate the Epione assistance for introducer placement during percutaneous procedures in musculo-skeletic (MSK) structures of the pelvis and the spine in adults. The main question is the determination of the rate of feasible procedures assisted by the Epione device Participants will undergo their procedure(s) as planned by their physician. If they accept to participate to the study, the differences with standard of care will be: * The use of the Epione device to place the introducer(s), instead of freehand placement if they do not participate * Additional CT or CBCT scans during the procedure.
Sites
- UC San DiegoSan Diego, California, United States
- Baptist Hospital Of Miami, IncMiami, Florida, United States
- Rush University Medical CenterChicago, Illinois, United States